FDA panel backs first-of-its-kind flu vaccine using mRNA technology
PBS
—
The Food and Drug Administration is evaluating Moderna's new shot, dubbed mFlusiva, for older Americans ahead of the winter flu season.
FDA Panel Backs Moderna mRNA Flu Shot
- FDA panel recommends Moderna’s mRNA flu shot for older adults NBC News —
- FDA panel recommends mRNA flu vaccine for older adults The Hill —
- FDA advisors unanimously vote to approve Moderna's mRNA after agency drama Ars Technica —
- Key FDA committee unanimously recommends its first vaccine since 2023 NPR —